id | Study | Lib. in paper | Exposition period | Study type |
Control type |
Tags | OR 95%CI | x1/n1 x0/n0 | no cases | no exposed | ROB | Ref. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
S3527 R6972 |
Spielmann (Control mainly exposed other treatments, sick), 2017 | Major birth defects | during pregnancy (anytime or not specified) | prospective cohort | exposed to other treatment, sick excluded | Adjustment: No |
2.04 [0.25;16.64] C excluded (control group) |
1/18 12/429 | 13 | 18 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S3528 R6973 |
Spielmann (Control unexposed, disease free), 2017 | Major birth defects | during pregnancy (anytime or not specified) excluded | prospective cohort | unexposed, disease free | Adjustment: No |
1.98 [0.26;15.22] C excluded (exposition period) |
1/18 44/1,526 | 45 | 18 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S3587 R7219 |
Nezvalová-Henriksen (Control unexposed, disease free), 2013 | Congenital malformations (major) | 1st trimester | population based cohort retrospective | unexposed, disease free excluded | Adjustment: No |
0.71 [0.26;1.91] C excluded (control group) |
4/189 5,292/178,565 | 5,296 | 189 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S3588 R7236 |
Nezvalová-Henriksen (Control unexposed, sick), 2013 | Congenital malformations (major) | 1st trimester | population based cohort retrospective | unexposed, sick | Adjustment: No | 0.32 [0.10;1.03] C | 4/189 11/174 | 15 | 189 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total | 1 studies | 0.32 [0.10;1.03] | 15 | 189 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives |
1: Control unexposed, sick;
Funnel plot not drawn. Less than 3 points.
Asymetry test p-value = NaN (by Egger's regression)
not enought points
Funnel plot not drawn. Less than 3 points.
excluded 3587, 3527